Greg Mullen

Professional Overview

Experience Summary

Current Role

• Current Position: Life Sciences Leader | Professional Sabbatical | Exploring New Opportunities

• Key Responsibilities and Achievements: During his current sabbatical, Greg is leveraging his extensive experience to explore new opportunities, further solidifying his expertise and network within the life sciences industry.

• Industry Impact: His current role reflects a strategic pause, allowing him to assess the landscape and identify potential areas for future impact, potentially in leadership roles within life sciences companies, leveraging his vast experience in operational management, scientific research, and executive leadership.

Career Progression

• Notable Previous Roles:

• Chief Operating Officer at Ariceum Therapeutics

• Chief Executive Officer and Chief Operating Officer at Theragnostics

• Chief Scientific Officer for Molecular Imaging at Mediso Medical Imaging Systems

• R&D Director at Oxford Immunotec

• Senior Lecturer in Imaging Biology at King's College London

• Head of Vaccine Formulation and Project Manager at National Institutes of Health

• Career Trajectory and Growth: Greg's career demonstrates a clear trajectory of growth from research and academic roles to executive leadership positions, showcasing his adaptability and capability to lead in various capacities within the life sciences sector.

• Key Achievements and Contributions: Throughout his career, Greg has made significant contributions to life sciences, particularly in molecular imaging, therapeutics, and vaccine formulation, indicating a strong background in both research and operational management.

Academic Background

• Due to the lack of specific information, this section cannot be completed.

Areas of Expertise

• Industry-specific Skills: Life sciences, therapeutics, molecular imaging, and vaccine formulation.

• Technical Competencies: Research and development, project management, and operational management.

• Leadership and Management Capabilities: Proven track record of leadership in executive roles, including CEO and COO positions, demonstrating strong strategic, operational, and team management skills.

Professional Impact

• Notable Projects or Initiatives: While specific projects are not detailed, Greg's roles suggest involvement in numerous significant projects, especially during his tenure as CEO, COO, and CSO in various life sciences companies.

• Industry Contributions: His work has likely contributed to advancements in therapeutics, molecular imaging, and vaccine formulation, reflecting his commitment to the life sciences industry.

• Measurable Achievements: Although specific metrics are not provided, his progression to senior executive roles indicates notable achievements and contributions to the companies he has worked with.

Conclusion

• Professional Trajectory: Greg Mullen's career path reflects a dedicated and accomplished life sciences professional, transitioning through various roles that highlight his expertise and leadership capabilities.

• Current Focus: Currently, Greg is focused on exploring new opportunities, positioning himself for future roles that leverage his expertise in life sciences leadership.

• Value Proposition: As a seasoned executive with a strong background in research, development, and operational management, Greg offers a unique blend of scientific acumen and leadership capabilities, making him a valuable asset to any organization within the life sciences sector.